Great Lakes Advisors LLC Invests $2.70 Million in Addus HomeCare Corporation $ADUS

Great Lakes Advisors LLC acquired a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 26,836 shares of the company’s stock, valued at approximately $2,696,000.

Several other large investors have also bought and sold shares of ADUS. Global Retirement Partners LLC raised its stake in Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares in the last quarter. Larson Financial Group LLC boosted its position in Addus HomeCare by 133.3% in the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC acquired a new stake in Addus HomeCare in the fourth quarter valued at approximately $29,000. Private Trust Co. NA grew its stake in shares of Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the last quarter. Finally, Arax Advisory Partners grew its stake in shares of Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after buying an additional 137 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ADUS. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Citizens Jmp restated a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, Barclays lifted their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $130.88.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $120.55 on Friday. The stock’s 50 day moving average is $108.92 and its 200 day moving average is $102.37. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $124.43. The firm has a market cap of $2.25 billion, a P/E ratio of 21.15, a P/E/G ratio of 1.61 and a beta of 0.87. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The business had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the prior year, the firm posted $1.49 EPS. The company’s revenue for the quarter was up 8.0% compared to the same quarter last year. As a group, research analysts expect that Addus HomeCare Corporation will post 6.29 EPS for the current year.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider directly owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.